19 research outputs found

    Evaluation de l'apport de l'IRM corps entier avec séquences de diffusion pour le suivi du myélome multiple

    No full text
    Introduction. L'IRM de diffusion est en cours d'évaluation dans le myélome multiple. L'objectif de notre étude était d'évaluer l'apport de l'IRM de diffusion corps entier pour le suivi de myélome. Méthodes. Chez 54 patients ayant eu 2 IRM corps entier avec séquences de diffusion pour le suivi d'un myélome, nous avons comparé évolution en IRM et évolution biologique. Nous avons aussi évalué l'apport des séquences de diffusion par rapport aux séquences classiques, et la concordance inter-observateurs pour l'interprétation des IRM. Résultats. L'évolution en IRM avec séquences de diffusion concordait avec l'évolution biologique dans 66,7% des cas. Cela équivalait à une concordance modérée (kappa pondéré 0,53), meilleure qu'en n'interprétant que les séquences T1 et STIR (kappa pondéré 0,50). La concordance inter-observateurs était modérée à bonne. Conclusion. L'IRM de diffusion corps entier évolue avec l'activité du myélome et semble un examen prometteur pour le suivi de cette pathologie.Introduction. Diffusion-weighted MRI (DWI) is currently evaluated in multiple myeloma. The aim of our study was to assess the interest of whole-body DWI (WB-DWI) for the follow-up of MM. Methods. 54 patients with myeloma underwent 2 WB-DWI at Rennes university hospital. We compared MRI changes to clinical evolution based on the international uniform response criteria. We also evaluated the impact of diffusion-weighted images compared to conventional MRI images, and the inter-observeur agreement. Results. We found an agreement between MRI changes and clinical evolution in 66,7% of cases. The weighted kappa coefficient was 0,53 (95% CI, 0,34 to 0,72), indicating moderate agreement, slightly higher than when taking into account only T1 and STIR weighted images (weighted kappa 0,50, 95% CI 0,31 to 0,69). Inter-observer agreement was moderate to good. Conclusion. WB-DWI correlates with clinical evolution and seems a promising technique for the follow-up of patients with MM.RENNES1-BU Santé (352382103) / SudocSudocFranceF

    Lineages with broad dairy biotope ranges and phenotypic variability in Propionibacterium freudenreichii revealed by multilocus sequence typing

    No full text
    Propionibacterium freudenreichii is used as a ripening culture in Swiss cheese and studied for its probiotic potentialities. Despite the reported variety of biotopes and phenotypes in the species, little is known about the P. freudenreichii population structure. The molecular diversity and the relationships between P. freudenreichii strains MLST scheme and sequence diversity were investigated using multilocus sequence typing (MLST

    Lineages with broad dairy biotope ranges and phenotypic variability in Propionibacterium freudenreichii revealed by multilocus sequence typing

    No full text
    Propionibacterium freudenreichii is used as a ripening culture in Swiss cheese and studied for its probiotic potentialities. Despite the reported variety of biotopes and phenotypes in the species, little is known about the P. freudenreichii population structure. The molecular diversity and the relationships between P. freudenreichii strains MLST scheme and sequence diversity were investigated using multilocus sequence typing (MLST

    Lineages with broad dairy biotope ranges and phenotypic variability in Propionibacterium freudenreichii revealed by multilocus sequence typing

    No full text
    Propionibacterium freudenreichii is used as a ripening culture in Swiss cheese and studied for its probiotic potentialities. Despite the reported variety of biotopes and phenotypes in the species, little is known about the P. freudenreichii population structure. The molecular diversity and the relationships between P. freudenreichii strains MLST scheme and sequence diversity were investigated using multilocus sequence typing (MLST

    CIRM : prĂ©server la biodiversitĂ© microbienne pour soutenir l’innovation

    No full text
    L’utilisation des micro-organismes est rĂ©gie par un cadre lĂ©gal et consensuel, actuellement en pleine Ă©volution. Le protocole de Nagoya et sa transposition rĂ©cente en droit français imposent dĂ©sormais une traçabilitĂ© complĂšte de toutes les souches de micro-organismes sur lesquelles les chercheurs travaillent. La Loi rĂšglemente notamment l’accĂšs aux ressources microbiennes prĂ©levĂ©es sur le territoire national ainsi que leur utilisation pour la recherche et le dĂ©veloppement. Le non-respect de cette loi est passible de consĂ©quences pĂ©nales et financiĂšres qui ne sont pas anodines.Les microorganismes jouent un rĂŽle essentiel dans de nombreux processus naturels et anthropiques. Il est indispensable de les prĂ©server et d’explorer leur diversitĂ©, en termes de recherche fondamentale mais aussi de recherche appliquĂ©e. Convaincu de leur importance, l’INRA a crĂ©Ă© en 2004, le Centre International de Ressources Microbiennes (CIRM) afin de valoriser ses collections patrimoniales de micro-organismes. Le CIRM est un rĂ©seau constituĂ© Ă  ce jour de cinq Centres de Ressources Biologiques (CRB) dont le CIRM-bactĂ©ries pathogĂšnes des animaux ou des humains basĂ© Ă  Tours. Le CIRM met Ă  la disposition de la communautĂ© scientifique et des industriels plus de 22000 souches. Il se distingue aujourd’hui des autres collections europĂ©ennes par le fait qu’il dispose d’un grand nombre de souches par espĂšce. AssociĂ©e Ă  l’expertise scientifique et technique de ses Ă©quipes et Ă  des outils analytiques haut-dĂ©bit, cette grande diversitĂ© intra-spĂ©cifique reprĂ©sente un potentiel d’innovation majeur permettant la comprĂ©hension des bases molĂ©culaires de la biodiversitĂ© phĂ©notypique ainsi que la recherche de fonctionnalitĂ©s d’intĂ©rĂȘt (aptitudes technologiques, activitĂ©s enzymatiques, caractĂšres phĂ©notypiques
) pouvant aboutir sur des applications industrielles. En tant que CRB certifiĂ© ISO 9001, le CIRM-BP offre la garantie du respect du cadre rĂ©glementaire et lĂ©gal.Le CIRM est devenu un acteur incontournable dans le paysage Français et EuropĂ©en des Ressources GĂ©nĂ©tiques: Il constitue le pilier Microbien de l’Infrastructure nationale de Recherche (IR) dĂ©diĂ©e aux ressources pour l’agronomie, RARe (http://www6.inra.fr/agrobrc-rare/) et joue dĂ©sormais un rĂŽle clĂ© dans la construction de l’IR europĂ©enne MIRRI (Microbial Resource Research Infrastructure/ http://mirri.org),. MIRRI vise Ă  faciliter l’accĂšs aux ressources microbiennes et leur utilisation par la recherche acadĂ©mique et industrielle et devrait impliquer Ă  terme plus de 300.000 isolats microbiens

    Multilocus sequence typing of Propionibacterium freudenreichii

    No full text
     Propionibacterium freudenreichii is used as a ripening culture in Swiss cheese manufacture. This study investigates the molecular diversity and the population structure of this bacterium via multilocus sequence typing (MLST). Internal fragments of seven genes sequenced for 113 strains of different subspecies and origins allowed the resolution of 46 sequence types (STs) with occurrence frequencies ranging from 1 to 11. The core genome of the species harbours a low level of nucleotide polymorphism. In our data, single nucleotide polymorphisms account for only 2.28% of the concatenated sequences, and the average polymorphism rate in pairwise comparisons is 0.46%. The analyses reveal quantitatively comparable contributions of recombination and mutation in nucleotide changes at core genome loci along cell lineages. Remarkably, the STs exhibit little if any dairy biotope specialization. Phenotypic characterisation of the strains, based on their aptitude to use lactose and nitrate, shows that the two previously identified subspecies (freudenreichii and shermani) do notreflect the ancestral relationships in the P. freudenreichii population. The considerable phenotypic heterogeneity, found even at the ST level, suggests instead a history of recurrent switches between phenotypes

    Evaluation of the diversity of two species of the genus Propionibacterium : Mass Spectrometry versus Triple-Locus Sequence Analysis

    No full text
    A preliminary study was performed on two species of Propionibacterium coming from very different biotope. The first specie, Propionibacterium acnes, is a commensal of the human skin. As an opportunistic pathogen, Propionibacterium acnes is involved in the pathogenesis of acne and may cause severe infections. The second specie, Propionibacterium freudenreichii belongs to the dairy group of propionic acid bacteria and is the main species involved in the holes and flavor formations in Swiss-type cheeses. The partial sequencing of genes coding for proteins (RpoB and RecA) and for 16S rRNA in addition to a mass spectrometric analysis of proteins (MALDI-TOF, MS) were applied to 20 strains of Propionibacterium acnes (15 from the collection of the National Reference Center for anaerobic bacteria and botulism from the Institut Pasteur and 5 strains from the Collection de l’Institut Pasteur) and to 20 strains of Propionibacterium freudenreichii from International Center of Microbial Ressources of Bacteria of Food Interest (CIRM-BIA, INRA). Main objective of this study is dual. Firstly, to determine the degree of molecular diversity of the strains at two levels, species level and clonal diversity level, taking into account that strains were selected in order to offer the largest diversity as possible in terms of biotopes and geographic origin for both species. Secondly, to compare the ranking of the strains according to the methodology applied: triple-locus sequence analysis or mass spectrometry. For mass spectrometry two equipments, an Applied Biosystems instrument and a Bruker Daltonics autoflex, were used to obtain mass spectra in order to evaluate and guarantee the reproducibility of the method. Results should also help to compare triple-locus sequence analysis to the MLST analysis which incorporates a greater number of genes

    Le CIRM : préserver la biodiversité microbienne pour innover

    No full text
    Les microorganismes sont des ressources gĂ©nĂ©tiques d’une valeur inestimable qu’il est indispensable de prĂ©server et d’explorer, en termes de recherche fondamentale mais aussi de recherche appliquĂ©e. Convaincu de cette richesse et de la valeur intrinsĂšque de la diversitĂ© intra-spĂ©cifique des microorganismes, l’INRA a crĂ©Ă© en 2006, le Centre International de Ressources Microbiennes (CIRM) afin de prĂ©server et de valoriser ses collections patrimoniales de micro-organismes. Le CIRM est un rĂ©seau constituĂ© Ă  ce jour de cinq Centres de Ressources Biologiques (CRB) thĂ©matiques - levures d’intĂ©rĂȘt technologique (Jouy-en-Josas), champignons filamenteux d’intĂ©rĂȘt agro-industriel (Marseille), bactĂ©ries alimentaires (Rennes), bactĂ©ries pathogĂšnes des animaux ou des humains (Tours) et bactĂ©ries associĂ©es aux plantes (Angers). L’exploitation et la valorisation de ces ressources prĂ©sentent des intĂ©rĂȘts et un impact socio-Ă©conomique dans des domaines aussi variĂ©s que les fermentations alimentaires, les biotechnologies blanche et verte ainsi que la lutte contre les phyto-pathogĂšnes et les infections bactĂ©riennes des animaux et de l’homme. Le CIRM met Ă  la disposition de la communautĂ© scientifique et des industriels plus de 22000 souches. Il se distingue aujourd’hui des autres collections europĂ©ennes par le fait qu’il dispose d’un grand nombre de souches par espĂšce. AssociĂ©e Ă  l’expertise scientifique et technique de ses Ă©quipes et Ă  des outils analytiques haut-dĂ©bit, cette trĂšs grande diversitĂ© intra-spĂ©cifique reprĂ©sente un potentiel d’innovation majeur permettant d’une part, la comprĂ©hension des bases molĂ©culaires de la biodiversitĂ© phĂ©notypique et d’autre part, la recherche de fonctionnalitĂ©s d’intĂ©rĂȘt (aptitudes technologiques, activitĂ©s enzymatiques, caractĂšres phĂ©notypiques
) pouvant aboutir sur des applications industrielles. Le CIRM, en tant que CRB certifiĂ© ISO 9001, offre la garantie du respect du cadre rĂ©glementaire et lĂ©gal actuellement en pleine Ă©volution, garantie essentielle Ă  toute dĂ©marche d’innovation que ce soit pour des collaborations de recherche ou des prestations de service

    Biogenic amine and antibiotic resistance profiles determined for lactic acid bacteria and a propionibacterium prior to use as antifungal bioprotective cultures

    No full text
    International audienceLactic acid bacteria (LAB) and propionibacteria are two microbial groups studied as alternatives tochemical preservatives in foods. As potential bioprotective cultures in the food industry, not only doesantimicrobial efficiency need to be ensured, but safety criteria should be evaluated. Here, 21 LAB and 1propionibacterium with previously determined antifungal properties were screened for two relevantcriteria: biogenic amine production and antibiotic resistance patterns. Low risk profiles were observedfor 15 strains, highlighting their potential industrial use as bioprotective cultures. Some exceptions wereidentified: both Lactobacillus buchneri strains tested were histamine-producers, while 1 Lactobacillusbrevis, 2 Lactobacillus rhamnosus and 1 Leuconostoc mesenteroides strains were tyramine-producers.These same strains were resistant to up to 5 antibiotics, thus excluding them as candidates for industrialuse. These results confirm the importance of ensuring safety criteria are met before considering acandidate strain for use as a bioprotective agent in food products
    corecore